48 results
8-K
EX-99.1
CLNN
Clene Inc
8 May 24
CLENE REPORTS First QUARTER 2024 FINANCIAL RESULTS AND RECENT OPERATING HIGHLIGHTS
8:01am
-MS and its long-term extension, and COVID-19 clinical trials, partially offset by an increase in expenses related to the two ongoing EAPs.
General
8-K
EX-99.1
CLNN
Clene Inc
13 Mar 24
Clene Reports Full Year 2023 Financial Results
8:02am
as completion of the trial for the treatment of COVID-19 with our CNM-ZnAg asset in 2022, partially offset by an increase in expenses related to the two ongoing … offset by higher finance and accounting fees.
Total other expense, net, was $9.0 million for the year ended December 31, 2023, compared to total
8-K
EX-99.1
owgtdedt9g 9z
7 Nov 23
Clene Reports Third Quarter 2023 Financial Results and Operating Highlights
8:02am
8-K
EX-99.1
ypq857
14 Aug 23
Clene Reports Second Quarter 2023 Financial Results and Operating Highlights
8:02am
8-K
EX-99.1
kmpvw3
12 May 23
Clene Reports First Quarter 2023 Financial Results and Recent Operating Highlights
4:07pm
8-K
EX-99.1
yyyl ponniu
15 Aug 22
Clene Reports Second Quarter 2022 Financial Results and Recent Operating Highlights
7:05am
8-K
EX-99.1
trqszntgjtnlfs33pcz
9 May 22
Clene Reports First Quarter 2022 Financial Results and Recent Operating Highlights
8:03am
8-K
EX-99.1
dqim69o9ogaz7
11 Mar 22
Clene Reports Full Year 2021 Financial Results and Recent Operating Highlights
7:04am